Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humanity Life Extension is a private U.S. healthcare and medical device company developing extracorporeal blood-treatment and whole-body systemic hyperthermia technologies for cancer treatment. Its lead platform, marketed as the HUMILITY Full Body Induced Systemic Hyperthermia Cancer Treatment, is described by the company as a method to safely elevate patient body temperature while managing blood chemistry and toxin removal during therapy. Public patent records indicate the company has built an intellectual-property estate around systems and methods for treating blood, including heat exchange and dialysis-based support approaches. The company appears to be focused primarily on device-enabled oncology treatment rather than conventional drug discovery, with limited public disclosure of a broader pipeline or formal late-stage clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Humanity Life Extension.